文献速递腹部MR

评估MRI多模型扩散加权成像对慢性乙型肝炎患者肝纤维化的临床价值

Evaluating the clinical value of MRI multi-model diffusion-weighted imaging on liver fibrosis in chronic hepatitis B patients.
PubMed 文献 · Abdom Radiol (NY) · 2020-10-13

前瞻性纳入146例慢性乙型肝炎患者和21名健康志愿者行肝脏DWI及体素内不相干运动MRI,获取单指数ADC、双指数D与D*及f、拉伸指数DDC与α,以肝穿刺病理分期为参考,比较各组参数并分析其与纤维化分级的相关性及对≥S2、≥S3的诊断效能,结果显示双指数D*与拉伸指数DDC在评估肝纤维化程度方面价值较好。

要点

  • 拉伸指数模型DDC对≥S2及≥S3的诊断效能最高,AUC分别为0.813与0.832
  • 双指数D*与DDC与肝纤维化分级呈中度负相关(r=-0.483与r=-0.622)
  • ADC、D*、f、DDC在正常对照组与肝纤维化组间差异均有统计学意义

核心结论

  • 双指数模型获得的D*与拉伸指数DWI获得的DDC在评估CHB患者肝纤维化程度方面有较好价值。
  • DDC在肝纤维化≥S2与≥S3的诊断效能最高,优于APRI与FIB-4。

研究设计与样本

  • 前瞻性研究,纳入146例慢性乙型肝炎患者和21名健康志愿者行肝脏DWI及体素内不相干运动MRI。
  • 以肝穿刺病理进行纤维化分期(S0-S4)作为参考标准。
  • 参数包括单指数模型ADC、双指数模型D、D*、f,以及拉伸指数模型DDC与α;同时检测AST、ALT、PLT并计算APRI与FIB-4。

诊断标准与关键数值

  • ADC、D、D*、f、DDC值在正常对照组与肝纤维化组间差异有统计学意义(P<0.05)。
  • ADC、D*、f、DDC值在不同肝纤维化分级组间差异有统计学意义(P<0.05)。
  • D*与肝纤维化分级呈中度负相关(r=-0.483,P<0.001),DDC呈中度负相关(r=-0.622,P<0.001)。
  • ADC与肝纤维化分级呈轻度负相关(r=-0.295,P<0.001),f呈轻度负相关(r=-0.312,P<0.001)。
  • DDC诊断≥S2的AUC为0.813、敏感度83.72%、特异度83.33%;诊断≥S3的AUC为0.832、敏感度73.53%、特异度66.04%,均优于APRI与FIB-4。

临床应用与阅片要点

  • 作者认为双指数模型D*与拉伸指数模型DDC在评估CHB肝纤维化程度方面有较好价值。
  • 原文未据此给出具体的阅片流程或报告推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore the value of various diffusion parameters obtained from monoexponential, biexponential, and stretched exponential in assessing liver fibrosis in chronic hepatitis B (CHB).

METHODS: DWI and intravoxel incoherent motion (IVIM) MRI were performed prospectively on liver for 146 patients with CHB and 21 healthy volunteers. ADC values were obtained from monoexponential model imaging. Diffusion coefficient (D), pseudodiffusion coefficient (D*), and perfusion fraction (f) obtained by biexponential model imaging, and stretched exponential model to obtain diffusion distribution coefficient (DDC) and diffusion heterogeneity index (α). Blood draw were performed on patients to obtain AST, ALT, and PLT, and then APRI and FIB-4 index were determined based on the serological diagnostic models. The fibrosis stage was staged (S0-S4) according to the pathology of liver puncture. Independent sample t test was used to compare the parameter values between liver fibrosis group and control group. One-way ANOVA was used to compare the parameters of different liver fibrosis grades. Bonferroni test was used for correcting multiple comparisons. Spearman correlation was used to analyze the correlation between each parameter and liver fibrosis grades. ROC was used to predict the diagnostic power of each parameter for liver fibrosis stages ≥ S2 and ≥ S3.

RESULTS: ADC, D, D*, f, and DDC values were significantly different between normal control group and hepatic fibrosis group (P < 0.05). There were significant differences in ADC, D*, f, and DDC value among liver fibrosis groups (P < 0.05). D* and DDC values were moderately negatively correlated with the grades of liver fibrosis (r = - 0.483, P < 0.001; r = - 0.622, P < 0.001). ADC and f values were slightly negatively correlated with the grades of liver fibrosis (r = - 0.295, P < 0.001; r = - 0.312, P < 0.001). DDC values have the highest diagnostic efficiency in liver fibrosis stages ≥ S2 and ≥ S3. The areas under ROC curve (AUC) were 0.813 and 0.832 for ≥ S2 and ≥ S3, respectively, the sensitivity is 83.72% and 73.53%, and the specificity of 83.33% and 66.04%, which were better than APRI and FIB-4.

CONCLUSION: D* obtained from biexponential and DDC obtained from stretched exponential DWI have better value in evaluating the degree of liver fibrosis in CHB.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Ren H, Liu Y, Lu J, et al. Evaluating the clinical value of MRI multi-model diffusion-weighted imaging on liver fibrosis in chronic hepatitis B patients. Abdom Radiol (NY). 2020. PMID: 33051757. doi:10.1007/s00261-020-02806-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。